Foresite, A Biotech Venture Firm, Reloads With $900m Fund

Foresite Capital, an investment firm focused on life sciences and healthcare companies, has raised a $900 million fund. The firm is particularly interested in companies using machine learning and genetics to identify potential drug programs. Over the years, Foresite has backed numerous successful companies and has also formed a startup incubator. Despite a recent recovery in the market, investors remain selective in their investments.